Results 131 to 140 of about 492,299 (347)
Pharmacy Practice, 2015 Background: Previous data reports inpatient antiretroviral (ARV) and opportunistic infection (OI) medication errors in as many as 86% of patients, with averages ranging from 1.16-2.7 errors/patient.
Chiampas TD, Kim H, Badowski M
doaj
Serotonergic Medication Error: A Case Report of Serotonin Syndrome. [PDF]
Cureus, 2023 Nguyen ATN +9 more
europepmc +1 more source
Decrypting cancer's spatial code: from single cells to tissue niches
Molecular Oncology, EarlyView.Spatial transcriptomics maps gene activity across tissues, offering powerful insights into how cancer cells are organised, switch states and interact with their surroundings. This review outlines emerging computational, artificial intelligence (AI) and geospatial approaches to define cell states, uncover tumour niches and integrate spatial data with ...
Cenk Celik +4 more
wiley +1 more source
Molecular Oncology, EarlyView.This study explores salivary RNA for breast cancer (BC) diagnosis, prognosis, and follow‐up. High‐throughput RNA sequencing identified distinct salivary RNA signatures, including novel transcripts, that differentiate BC from healthy controls, characterize histological and molecular subtypes, and indicate lymph node involvement.
Nicholas Rajan +9 more
wiley +1 more source
Integrated Pharmacy Research and Practice, 2020 Desalegn Feyissa, Bezie Kebede, Ameha Zewudie, Yitagesu Mamo Department of Pharmacy, College of Medicine and Health Science, Mizan-Tepi University, Mizan-Aman, EthiopiaCorrespondence: Desalegn Feyissa Tel +251 917127556Email sinaawayya@gmail ...
Feyissa D, Kebede B, Zewudie A, Mamo Y
doaj
Methotrexate-Induced Mucositis: A Consequence of Medication Error in a Rheumatoid Arthritis Patient. [PDF]
Cureus, 2023 Shrestha R +4 more
europepmc +1 more source
Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology
Molecular Oncology, EarlyView.Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts +8 more
wiley +1 more source
Therapeutics and Clinical Risk Management, 2008 Khurshid Khowaja1, Rozmin Nizar1, Rashida J Merchant2, Jacqueline Dias3, Irma Bustamante-Gavino4, Amina Malik11Division of Nursing Services, 2Nursing Education Services, 3Diploma Programme, Nurudin Jivraj Professorship of Nursing, Aga Khan University ...
Khurshid Khowaja +5 more
doaj
, 2011 Overview: Time of Death: 5:07 p.m. – Proceeding the solemn afternoon of February 22nd 2003, the Santillian family listened on as doctors told them that their cherished loved one was officially pronounced brain dead and would soon have to be taken off ...
Spall, Jennifer
core +1 more source